| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | BIOS HEALTH LTD | 8 BATEMAN MEWS | CAMBRIDGE | CAMBRIDGESHIRE | | | GBR | OT2OD030536 | Efficient mapping of neuromodulation therapy parameters to complex biomarker spaces | 000 | 1 | NIH | 10/26/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $525,696 ) |
| | 2022 | 2022 | BIOS HEALTH LTD | 8 BATEMAN MEWS | CAMBRIDGE | CAMBRIDGESHIRE | | | GBR | OT2OD030536 | Efficient mapping of neuromodulation therapy parameters to complex biomarker spaces | 001 | 1 | NIH | 1/1/2022 | $525,696 |
| | 2022 | 2021 | BIOS HEALTH LTD | 8 BATEMAN MEWS | CAMBRIDGE | CAMBRIDGESHIRE | | | GBR | OT2OD030536 | Efficient mapping of neuromodulation therapy parameters to complex biomarker spaces | 000 | 1 | NIH | 12/31/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $859,337 ) |
| | 2021 | 2021 | BIOS HEALTH LTD | 8 BATEMAN MEWS | CAMBRIDGE | CAMBRIDGESHIRE | | | GBR | OT2OD030536 | Efficient mapping of neuromodulation therapy parameters to complex biomarker spaces | 000 | 1 | NIH | 1/13/2021 | $859,337 |
|
|
